All Stories

  1. Niosomal Encapsulation of Anti-cancer Peptides: A Revolutionary Strategy in Cancer Therapy
  2. A New RP-HPLC method for stability indicating assay of pazopanib hydrochloride in tablet dosage form: method development, validation, and degradation kinetics
  3. Harnessing the Power of Ferulic Acid: A Comprehensive Review of its Therapeutic Mechanisms, Delivery Innovations, and Clinical Impact
  4. Pharmaceutical Industry Manufacturing Trend for Tablet Dosage Forms and Opportunities for the Future; A Case Study of Current Practice and Future Developments
  5. Stability-indicating instrumental thin-layer chromatography method for the quantification of dapagliflozin propanediol monohydrate and bisoprolol fumarate with implementation of fractional factorial design
  6. Unveiling the Potential of Morpholinium Surface Active Ionic Liquids for Epidermal Growth Factor Receptor Inhibition: Synthesis, Integrating Molecular Docking, Dynamics, and In Vitro Studies
  7. Identification and assessment of novel degradants in pazopanib hydrochloride using stability-indicating RP-HPLC method
  8. Quality by Design Approach Driven Development and Validation of Reverse Phase‐High‐Performance Liquid Chromatography Methodology for Dual Quantification of Aspirin and Rivaroxaban
  9. Synthesis and InhA Inhibition of Imidazo[1,2-a]pyridine Derivatives as Anti-Tuberculosis Agents
  10. A validated HPTLC method for quantification of a new combination containing Lidocaine HCl and Diltiazem HCl
  11. Pharmaceutical Market Access in Latin America: Analyzing Approval Requirements in Three Key Nations: Ecuador, Dominican Republic and Nicaragua
  12. Computational Exploration of Naturally Occurring Flavonoids as TGF‐β Inhibitors in Breast Cancer: Insights from Docking and Molecular Dynamics Simulations and In‐vitro Cytotoxicity Study
  13. Atorvastatin's Reduction of Alzheimer's Disease and Possible Alteration of Cognitive Function in Midlife as well as its Treatment
  14. Emerging green synthetic routes for thiazole and its derivatives: Current perspectives
  15. Prominent Targets for Cancer Care: Immunotherapy Perspective
  16. Nanomaterials as drug delivery agents for overcoming the blood-brain barrier: A comprehensive review
  17. Review on Determination of Berberine in Biological and Pharmaceutical Matrices: An Analytical and Therapeutic Perspective
  18. Antibody drug conjugates as targeted cancer therapy: past development, present challenges and future opportunities
  19. DE-INTERACT: A machine-learning-based predictive tool for the drug-excipient interaction study during product development—Validation through paracetamol and vanillin as a case study
  20. Development and application of HPTLC method for estimation of Rivaroxaban and Aspirin in bulk drug and in-house tablet form
  21. Xenobots: Applications in Drug Discovery
  22. Review on Analytical Methodologies, Chemical and Therapeutic Perspectives of Curcumin: A Ubiquitous Natural Molecule
  23. Role of Natural and Synthetic Flavonoids as Potential Aromatase Inhibitors in Breast Cancer: Structure-Activity Relationship Perspective
  24. Chemopreventive Role of Phytoconstituents in Breast Cancer: An Integration Therapy
  25. Method development and validation of cabozantinib by LC-MS/MS
  26. Probiotic Formulations: A Patent Landscaping Using the Text Mining Approach
  27. A review on synthetic investigation for quinoline- recent green approaches
  28. In Vitro Cytotoxicity and Aromatase Inhibitory Activity of Flavonoids: Synthesis, Molecular Docking and In silico ADME Prediction
  29. Comprehensive Review of Ethnopharmacological and Phytochemical Aspects of Nutraceuticals in Psychiatric Disorders
  30. Comprehensive review on repurposing of approved medicine in the management of COVID-19 infection
  31. Practicality Assessment of a Frugal Nanoparticle Generator: Opening Doors to Nano Pharmaceuticals for the Researchers and Students of Underprivileged Academic Institutions
  32. Molecular modeling and ADMET predictions of flavonoids as prospective aromatase inhibitors
  33. Piperine: Medicinal, Analytical and Therapeutics perspective
  34. Pharmacological Study of A3 Adenosine Receptor agonist (AB Meca) in Xenograft Lung Cancer Model in Mice through In Silico and In Vivo Approach: Targeting TNF-α
  35. Development of a quick reverse phase liquid chromatographic method with photodiode-array detection for quantitative determination of chlorthalidone, metoprolol succinate and telmisartan in tablet formulation
  36. Quinoxaline as Ubiquitous Structural Fragment: An Update on the Recent Development of its Green Synthetic Approaches
  37. A Review: Method Development Validation and Degradation Studies of some Anticancer Drugs
  38. Method Development and Validation of Degradation Studies of Lenalidomide by RP-HPLC
  39. Ultrasound-Assisted One-Pot Synthesis of Tetrahydropyrimidne Derivatives through Biginelli Condensation: A Catalyst Free Green Chemistry Approach
  40. Review and Analysis of Massively Registered Clinical Trials of COVID-19 using the Text Mining Approach
  41. Simultaneous quantification of teneligliptin hydrobromide and metformin hydrochloride: An improved HPTLC method with implementation of Plackett-Burman design
  42. A Review on the Synthetic Approach of Marinopyrroles: A Natural Anti-tumor Agent from the Ocean
  43. Collocating novel targets for Tuberculosis (TB) Drug Discovery
  44. APPLICATION OF CHEMOMETRIC METHODS FOR THE DETERMINATION OF CIPROFLOXACIN HYDROCHLORIDE AND PHENAZOPYRIDINE HYDROCHLORIDE IN THEIR PHARMACEUTICAL DOSAGE FORM
  45. DEVELOPMENT AND VALIDATION OF A HIGH-PERFORMANCE THIN-LAYER CHROMATOGRAPHY FOR THE DETERMINATION OF TERBUTALINE SULFATE, BROMHEXINE HYDROCHLORIDE, AND ETOPHYLLINE IN PHARMACEUTICAL DOSAGE FORM
  46. Molecular Docking, In-Silico ADMET Study and Development of 1,6- Dihydropyrimidine Derivative as Protein Tyrosine Phosphatase Inhibitor: An Approach to Design and Develop Antidiabetic Agents
  47. Molecular Docking, Synthesis and Biological Evaluation of Sulphonylureas/ Guanidine Derivatives as Promising Antidiabetic Agent
  48. Synthesis of Novel Fluoroquinolone using Molecular Docking
  49. Molecular Docking and In Silico ADMET Study Reveals Flavonoids as a Potential Inhibitor of Aromatase
  50. DEVELOPMENT AND VALIDATION OF HPTLC METHOD FOR SIMULTANEOUS ESTIMATION OF TERBINAFINE HYDROCHLORIDE AND MOMETASONE FUROATE IN COMBINED DOSAGE FORM
  51. Proton pump inhibitors: recent developments in analytical methodologies
  52. Design, Synthesis, Molecular Docking, and Antibacterial Evaluation of Some Novel Flouroquinolone Derivatives as Potent Antibacterial Agent
  53. Design, Synthesis, Biological Screening and Structure Activity Relationship Study of 4, 6-Dimethyl-2-(Substituted) Mercapto-3-(Substituted) Pyridines as Anti Tubercular Agents